Anemia and Inflammation

NCT03618914 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-08-22

No results posted yet for this study

Summary

During inflammation hepcidin concentrations are increased, leading to a decrease in iron absorption. In iron deficiency anemia hepcidin is suppressed due to the activation of erythropoiesis. Whether inflammation or anemia has the stronger effect on hepcidin is uncertain.

Conditions

Interventions

BIOLOGICAL

Dultavax and Vaxigrip

All the women got an influenza/DTP vaccine in order to induce acute inflammation

Sponsors & Collaborators

  • Ibn Tofail University-CNESTEN

    collaborator UNKNOWN
  • Swiss Federal Institute of Technology

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-15
Primary Completion
2018-03-29
Completion
2018-06-30

Countries

  • Morocco

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03618914 on ClinicalTrials.gov